207 related articles for article (PubMed ID: 35404564)
1. Drug-Repurposing Screening Identified Tropifexor as a SARS-CoV-2 Papain-like Protease Inhibitor.
Ma C; Hu Y; Wang Y; Choza J; Wang J
ACS Infect Dis; 2022 May; 8(5):1022-1030. PubMed ID: 35404564
[TBL] [Abstract][Full Text] [Related]
2. Drug Repurposing for the SARS-CoV-2 Papain-Like Protease.
Cho CC; Li SG; Lalonde TJ; Yang KS; Yu G; Qiao Y; Xu S; Ray Liu W
ChemMedChem; 2022 Jan; 17(1):e202100455. PubMed ID: 34423563
[TBL] [Abstract][Full Text] [Related]
3. Structure-Based Identification of Naphthoquinones and Derivatives as Novel Inhibitors of Main Protease M
Santos LH; Kronenberger T; Almeida RG; Silva EB; Rocha REO; Oliveira JC; Barreto LV; Skinner D; Fajtová P; Giardini MA; Woodworth B; Bardine C; Lourenço AL; Craik CS; Poso A; Podust LM; McKerrow JH; Siqueira-Neto JL; O'Donoghue AJ; da Silva Júnior EN; Ferreira RS
J Chem Inf Model; 2022 Dec; 62(24):6553-6573. PubMed ID: 35960688
[TBL] [Abstract][Full Text] [Related]
4. Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease.
Tan H; Hu Y; Jadhav P; Tan B; Wang J
J Med Chem; 2022 Jun; 65(11):7561-7580. PubMed ID: 35620927
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture.
Bafna K; White K; Harish B; Rosales R; Ramelot TA; Acton TB; Moreno E; Kehrer T; Miorin L; Royer CA; García-Sastre A; Krug RM; Montelione GT
Cell Rep; 2021 May; 35(7):109133. PubMed ID: 33984267
[TBL] [Abstract][Full Text] [Related]
6. Discovery of SARS-CoV-2 papain-like protease inhibitors through a combination of high-throughput screening and FlipGFP-based reporter assay.
Xia Z; Sacco MD; Ma C; Townsend JA; Kitamura N; Hu Y; Ba M; Szeto T; Zhang X; Meng X; Zhang F; Xiang Y; Marty MT; Chen Y; Wang J
bioRxiv; 2021 Mar; ():. PubMed ID: 33758866
[TBL] [Abstract][Full Text] [Related]
7. Natural biflavones are potent inhibitors against SARS-CoV-2 papain-like protease.
Li L; Ma L; Hu Y; Li X; Yu M; Shang H; Zou Z
Phytochemistry; 2022 Jan; 193():112984. PubMed ID: 34757253
[TBL] [Abstract][Full Text] [Related]
8. Structure-based design of SARS-CoV-2 papain-like protease inhibitors.
Jadhav P; Huang B; Osipiuk J; Zhang X; Tan H; Tesar C; Endres M; Jedrzejczak R; Tan B; Deng X; Joachimiak A; Cai J; Wang J
Eur J Med Chem; 2024 Jan; 264():116011. PubMed ID: 38065031
[TBL] [Abstract][Full Text] [Related]
9. Repurposing the antibacterial drugs for inhibition of SARS-CoV2-PLpro using molecular docking, MD simulation and binding energy calculation.
Patel R; Prajapati J; Rao P; Rawal RM; Saraf M; Goswami D
Mol Divers; 2022 Aug; 26(4):2189-2209. PubMed ID: 34591234
[TBL] [Abstract][Full Text] [Related]
10. High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors.
Zhao Y; Du X; Duan Y; Pan X; Sun Y; You T; Han L; Jin Z; Shang W; Yu J; Guo H; Liu Q; Wu Y; Peng C; Wang J; Zhu C; Yang X; Yang K; Lei Y; Guddat LW; Xu W; Xiao G; Sun L; Zhang L; Rao Z; Yang H
Protein Cell; 2021 Nov; 12(11):877-888. PubMed ID: 33864621
[TBL] [Abstract][Full Text] [Related]
11. Compounds derived from Humulus lupulus inhibit SARS-CoV-2 papain-like protease and virus replication.
Herzog AM; Göbel K; Marongiu L; Ruetalo N; Alonso MC; Leischner C; Busch C; Burkard M; Lauer UM; Geurink PP; Knobeloch KP; Schindler M; Fritz G; Venturelli S
Phytomedicine; 2024 Jan; 123():155176. PubMed ID: 37976697
[TBL] [Abstract][Full Text] [Related]
12. Interaction of small molecules with the SARS-CoV-2 papain-like protease: In silico studies and in vitro validation of protease activity inhibition using an enzymatic inhibition assay.
Pitsillou E; Liang J; Ververis K; Hung A; Karagiannis TC
J Mol Graph Model; 2021 May; 104():107851. PubMed ID: 33556646
[TBL] [Abstract][Full Text] [Related]
13. Repurposing clinically approved drugs for COVID-19 treatment targeting SARS-CoV-2 papain-like protease.
Xu Y; Chen K; Pan J; Lei Y; Zhang D; Fang L; Tang J; Chen X; Ma Y; Zheng Y; Zhang B; Zhou Y; Zhan J; Xu W
Int J Biol Macromol; 2021 Oct; 188():137-146. PubMed ID: 34364941
[TBL] [Abstract][Full Text] [Related]
14. Unraveling antiviral efficacy of multifunctional immunomodulatory triterpenoids against SARS-COV-2 targeting main protease and papain-like protease.
Choudhary S; Nehul S; Singh A; Panda PK; Kumar P; Sharma GK; Tomar S
IUBMB Life; 2024 May; 76(5):228-241. PubMed ID: 38059400
[TBL] [Abstract][Full Text] [Related]
15. High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors.
Zang Y; Su M; Wang Q; Cheng X; Zhang W; Zhao Y; Chen T; Jiang Y; Shen Q; Du J; Tan Q; Wang P; Gao L; Jin Z; Zhang M; Li C; Zhu Y; Feng B; Tang B; Xie H; Wang MW; Zheng M; Pan X; Yang H; Xu Y; Wu B; Zhang L; Rao Z; Yang X; Jiang H; Xiao G; Zhao Q; Li J
Protein Cell; 2023 Jan; 14(1):17-27. PubMed ID: 36726755
[TBL] [Abstract][Full Text] [Related]
16. Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2.
Shan H; Liu J; Shen J; Dai J; Xu G; Lu K; Han C; Wang Y; Xu X; Tong Y; Xiang H; Ai Z; Zhuang G; Hu J; Zhang Z; Li Y; Pan L; Tan L
Cell Chem Biol; 2021 Jun; 28(6):855-865.e9. PubMed ID: 33979649
[TBL] [Abstract][Full Text] [Related]
17. Mass Spectrometric Assays Reveal Discrepancies in Inhibition Profiles for the SARS-CoV-2 Papain-Like Protease.
Brewitz L; Kamps JJAG; Lukacik P; Strain-Damerell C; Zhao Y; Tumber A; Malla TR; Orville AM; Walsh MA; Schofield CJ
ChemMedChem; 2022 May; 17(9):e202200016. PubMed ID: 35085423
[TBL] [Abstract][Full Text] [Related]
18. Virtual screening of phytoconstituents from miracle herb
Siddiqui S; Upadhyay S; Ahmad R; Gupta A; Srivastava A; Trivedi A; Husain I; Ahmad B; Ahamed M; Khan MA
J Biomol Struct Dyn; 2022 Jun; 40(9):3928-3948. PubMed ID: 33289456
[TBL] [Abstract][Full Text] [Related]
19. A Patent Review on SARS Coronavirus Papain-Like Protease (PL
Brian Chia CS; Pheng Lim S
ChemMedChem; 2023 Aug; 18(16):e202300216. PubMed ID: 37248169
[TBL] [Abstract][Full Text] [Related]
20. Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay.
Ma C; Sacco MD; Xia Z; Lambrinidis G; Townsend JA; Hu Y; Meng X; Szeto T; Ba M; Zhang X; Gongora M; Zhang F; Marty MT; Xiang Y; Kolocouris A; Chen Y; Wang J
ACS Cent Sci; 2021 Jul; 7(7):1245-1260. PubMed ID: 34341772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
